These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 39162154)

  • 1. [Precision psychiatry and neuroimaging: Towards improved treatment success in psychosis].
    van Hooijdonk CFM; Booij J; van de Giessen E; Selten JP; van Amelsvoort TAMJ
    Tijdschr Psychiatr; 2024; 66(6):308-315. PubMed ID: 39162154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutamatergic and dopaminergic function and the relationship to outcome in people at clinical high risk of psychosis: a multi-modal PET-magnetic resonance brain imaging study.
    Howes OD; Bonoldi I; McCutcheon RA; Azis M; Antoniades M; Bossong M; Modinos G; Perez J; Stone JM; Santangelo B; Veronese M; Grace A; Allen P; McGuire PK
    Neuropsychopharmacology; 2020 Mar; 45(4):641-648. PubMed ID: 31618752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuromelanin-Sensitive MRI as Candidate Marker for Treatment Resistance in First-Episode Schizophrenia.
    van der Pluijm M; Wengler K; Reijers PN; Cassidy CM; Tjong Tjin Joe K; de Peuter OR; Horga G; Booij J; de Haan L; van de Giessen E
    Am J Psychiatry; 2024 Jun; 181(6):512-519. PubMed ID: 38476044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opportunities in precision psychiatry using PET neuroimaging in psychosis.
    Coughlin JM; Horti AG; Pomper MG
    Neurobiol Dis; 2019 Nov; 131():104428. PubMed ID: 30904669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopaminergic alterations in populations at increased risk for psychosis: A systematic review of imaging findings.
    van Hooijdonk CFM; Drukker M; van de Giessen E; Booij J; Selten JP; van Amelsvoort TAMJ
    Prog Neurobiol; 2022 Jun; 213():102265. PubMed ID: 35351599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine and Glutamate in Antipsychotic-Responsive Compared With Antipsychotic-Nonresponsive Psychosis: A Multicenter Positron Emission Tomography and Magnetic Resonance Spectroscopy Study (STRATA).
    Egerton A; Murphy A; Donocik J; Anton A; Barker GJ; Collier T; Deakin B; Drake R; Eliasson E; Emsley R; Gregory CJ; Griffiths K; Kapur S; Kassoumeri L; Knight L; Lambe EJB; Lawrie SM; Lees J; Lewis S; Lythgoe DJ; Matthews J; McGuire P; McNamee L; Semple S; Shaw AD; Singh KD; Stockton-Powdrell C; Talbot PS; Veronese M; Wagner E; Walters JTR; Williams SR; MacCabe JH; Howes OD
    Schizophr Bull; 2021 Mar; 47(2):505-516. PubMed ID: 32910150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effective connectivity within a triple network brain system discriminates schizophrenia spectrum disorders from psychotic bipolar disorder at the single-subject level.
    Palaniyappan L; Deshpande G; Lanka P; Rangaprakash D; Iwabuchi S; Francis S; Liddle PF
    Schizophr Res; 2019 Dec; 214():24-33. PubMed ID: 29398207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated Striatal Dopamine Function in Immigrants and Their Children: A Risk Mechanism for Psychosis.
    Egerton A; Howes OD; Houle S; McKenzie K; Valmaggia LR; Bagby MR; Tseng HH; Bloomfield MA; Kenk M; Bhattacharyya S; Suridjan I; Chaddock CA; Winton-Brown TT; Allen P; Rusjan P; Remington G; Meyer-Lindenberg A; McGuire PK; Mizrahi R
    Schizophr Bull; 2017 Mar; 43(2):293-301. PubMed ID: 28057720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preliminary data indicating a connection between stress-induced prefrontal dopamine release and hippocampal TSPO expression in the psychosis spectrum.
    Schifani C; Hafizi S; Tseng HH; Gerritsen C; Kenk M; Wilson AA; Houle S; Rusjan PM; Mizrahi R
    Schizophr Res; 2019 Nov; 213():80-86. PubMed ID: 30409695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frontostriatothalamic effective connectivity and dopaminergic function in the psychosis continuum.
    Sabaroedin K; Razi A; Chopra S; Tran N; Pozaruk A; Chen Z; Finlay A; Nelson B; Allott K; Alvarez-Jimenez M; Graham J; Yuen HP; Harrigan S; Cropley V; Sharma S; Saluja B; Williams R; Pantelis C; Wood SJ; O'Donoghue B; Francey S; McGorry P; Aquino K; Fornito A
    Brain; 2023 Jan; 146(1):372-386. PubMed ID: 35094052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Schizophrenia, Dopamine and the Striatum: From Biology to Symptoms.
    McCutcheon RA; Abi-Dargham A; Howes OD
    Trends Neurosci; 2019 Mar; 42(3):205-220. PubMed ID: 30621912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine synthesis capacity before onset of psychosis: a prospective [18F]-DOPA PET imaging study.
    Howes OD; Bose SK; Turkheimer F; Valli I; Egerton A; Valmaggia LR; Murray RM; McGuire P
    Am J Psychiatry; 2011 Dec; 168(12):1311-7. PubMed ID: 21768612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between cortical glutamate and striatal dopamine in first-episode psychosis: a cross-sectional multimodal PET and magnetic resonance spectroscopy imaging study.
    Jauhar S; McCutcheon R; Borgan F; Veronese M; Nour M; Pepper F; Rogdaki M; Stone J; Egerton A; Turkheimer F; McGuire P; Howes OD
    Lancet Psychiatry; 2018 Oct; 5(10):816-823. PubMed ID: 30236864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Test of the Transdiagnostic Dopamine Hypothesis of Psychosis Using Positron Emission Tomographic Imaging in Bipolar Affective Disorder and Schizophrenia.
    Jauhar S; Nour MM; Veronese M; Rogdaki M; Bonoldi I; Azis M; Turkheimer F; McGuire P; Young AH; Howes OD
    JAMA Psychiatry; 2017 Dec; 74(12):1206-1213. PubMed ID: 29049482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Structural Magnetic Resonance Imaging Measures With Psychosis Onset in Individuals at Clinical High Risk for Developing Psychosis: An ENIGMA Working Group Mega-analysis.
    ; Jalbrzikowski M; Hayes RA; Wood SJ; Nordholm D; Zhou JH; Fusar-Poli P; Uhlhaas PJ; Takahashi T; Sugranyes G; Kwak YB; Mathalon DH; Katagiri N; Hooker CI; Smigielski L; Colibazzi T; Via E; Tang J; Koike S; Rasser PE; Michel C; Lebedeva I; Hegelstad WTV; de la Fuente-Sandoval C; Waltz JA; Mizrahi R; Corcoran CM; Resch F; Tamnes CK; Haas SS; Lemmers-Jansen ILJ; Agartz I; Allen P; Amminger GP; Andreassen OA; Atkinson K; Bachman P; Baeza I; Baldwin H; Bartholomeusz CF; Borgwardt S; Catalano S; Chee MWL; Chen X; Cho KIK; Cooper RE; Cropley VL; Dolz M; Ebdrup BH; Fortea A; Glenthøj LB; Glenthøj BY; de Haan L; Hamilton HK; Harris MA; Haut KM; He Y; Heekeren K; Heinz A; Hubl D; Hwang WJ; Kaess M; Kasai K; Kim M; Kindler J; Klaunig MJ; Koppel A; Kristensen TD; Kwon JS; Lawrie SM; Lee J; León-Ortiz P; Lin A; Loewy RL; Ma X; McGorry P; McGuire P; Mizuno M; Møller P; Moncada-Habib T; Muñoz-Samons D; Nelson B; Nemoto T; Nordentoft M; Omelchenko MA; Oppedal K; Ouyang L; Pantelis C; Pariente JC; Raghava JM; Reyes-Madrigal F; Roach BJ; Røssberg JI; Rössler W; Salisbury DF; Sasabayashi D; Schall U; Schiffman J; Schlagenhauf F; Schmidt A; Sørensen ME; Suzuki M; Theodoridou A; Tomyshev AS; Tor J; Værnes TG; Velakoulis D; Venegoni GD; Vinogradov S; Wenneberg C; Westlye LT; Yamasue H; Yuan L; Yung AR; van Amelsvoort TAMJ; Turner JA; van Erp TGM; Thompson PM; Hernaus D
    JAMA Psychiatry; 2021 Jul; 78(7):753-766. PubMed ID: 33950164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuromelanin-sensitive MRI as a noninvasive proxy measure of dopamine function in the human brain.
    Cassidy CM; Zucca FA; Girgis RR; Baker SC; Weinstein JJ; Sharp ME; Bellei C; Valmadre A; Vanegas N; Kegeles LS; Brucato G; Kang UJ; Sulzer D; Zecca L; Abi-Dargham A; Horga G
    Proc Natl Acad Sci U S A; 2019 Mar; 116(11):5108-5117. PubMed ID: 30796187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between grey matter volume and striatal dopamine function in psychosis: a multimodal
    D'Ambrosio E; Jauhar S; Kim S; Veronese M; Rogdaki M; Pepper F; Bonoldi I; Kotoula V; Kempton MJ; Turkheimer F; Kwon JS; Kim E; Howes OD
    Mol Psychiatry; 2021 Apr; 26(4):1332-1345. PubMed ID: 31690805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The integrated model of glutamate and dopamine hypothesis for schizophrenia: Prediction and personalized medicine for prevent potential treatment-resistant patients.
    Huang LC; Lin SH; Tseng HH; Chen KC; Yang YK
    Med Hypotheses; 2020 Oct; 143():110159. PubMed ID: 32795840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multimodal Neuroimaging Summary Scores as Neurobiological Markers of Psychosis.
    Rodrigue AL; Hayes RA; Waite E; Corcoran M; Glahn DC; Jalbrzikowski M
    Schizophr Bull; 2024 Jul; 50(4):792-803. PubMed ID: 37844289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebral blood flow in schizophrenia: A systematic review and meta-analysis of MRI-based studies.
    Percie du Sert O; Unrau J; Gauthier CJ; Chakravarty M; Malla A; Lepage M; Raucher-Chéné D
    Prog Neuropsychopharmacol Biol Psychiatry; 2023 Mar; 121():110669. PubMed ID: 36341843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.